MINIMALLY INVASIVE SUBTOTAL ESOPHAGECTOMY IN ESOPHAGE-GASTRIC TRANSITION ADENOCARCINOMA

In recent decades, the frequency of adenocarcinoma at the esophagogastric junction has increased considerably. When its surgical treatment is indicated, we know that occasionally a thoracotomy and laparotomy is necessary, bringing a high mortality and morbidity rate. In recent years, minimally invasive approaches to esophagectomy have been adopted to minimize perioperative risk, in addition to offering longer lymph node dissection, shorter hospital stays and similar survival outcomes when compared with the open technique. In this video, we demonstrate the surgical treatment of a 38-year-old male patient diagnosed with esophagogastric transition adenocarcinoma, who had an ulcerative infiltrative lesion at 35cm from the ADS. In June 2018 a stent videolaparoscopy was performed, which did not show peritoneal disease, and was then submitted to 4 cycles of neoadjuvant chemotherapy (FLOT scheme), with good response by the restaging exams. The patient underwent minimally invasive subtotal esophagectomy without complications and had a good postoperative clinical and surgical evolution.

 

MissingLinkText

No conflict of interest has been declared by the author(s).

Publication History

Article published online:
23 October 2019